Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoko Takebe

Showing results (21-30 of 140) with videos related to

Pageof 14
Sort By:
Human Vaccines & Immunotherapeutics|December 16, 2020
The emerging landscape of immune checkpoint inhibitor based clinical trials in adults with advanced rare tumorsArjun Mittra, Naoko Takebe, Vaia Florou, et al.
Cells|May 13, 2023
Rethinking Oncologic Treatment Strategies with Interleukin-2Brian Ko, Naoko Takebe, Omozusi Andrews, et al.
Iscience|October 25, 2021
Schlafen 11 expression in human acute leukemia cells with gain-of-function mutations in the interferon-JAK signaling pathwayYasuhisa Murai, Ukhyun Jo, Junko Murai, et al.
Cancer Journal (Sudbury, Mass.)|July 24, 2019
Defining, Identifying, and Understanding "Exceptional Responders" in Oncology Using the Tools of Precision MedicineApostolia M Tsimberidou, Rabih Said, Louis M Staudt, et al.
The Journal of Biological Chemistry|May 10, 2012
Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) activity by small molecule GMX1778 regulates reactive oxygen species (ROS)-mediated cytotoxicity in a p53- and nicotinic acid phosphoribosyltransferase1 (NAPRT1)-dependent mannerDavid Cerna, Hongyun Li, Siobhan Flaherty, et al.
Growth Factors (Chur, Switzerland)|December 1, 2007
Human brain endothelial cells (HUBEC) promote SCID repopulating cell expansion through direct contactXiangfei Cheng, Thomas Macvittie, Barry Meisenberg, et al.
Cancer Gene Therapy|March 16, 2002
Methotrexate selection of long-term culture initiating cells following transduction of CD34(+) cells with a retrovirus containing a mutated human dihydrofolate reductase geneNaoko Takebe, Li-Cheng Xu, Karen L MacKenzie, et al.
Current Problems in Cancer|January 5, 2024
Blood-based multi-cancer detection: A state-of-the-art updateMaria Farooq, Elyse Leevan, Jibran Ahmed, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 12, 2016
Analysis of esophagogastric cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase 1 trialsHideaki Bando, Larry Rubinstein, Pamela Harris, et al.
Gynecologic Oncology|November 6, 2009
NIH and NCI support for development of novel therapeutics in gynecologic cancer: a user's guideLucas Minig, Edward L Trimble, Michael J Birrer, et al.
Pageof 14

Showing results (21-30 of 140) with videos related to

Sort By:
Pageof 14
Human Vaccines & Immunotherapeutics|December 16, 2020
The emerging landscape of immune checkpoint inhibitor based clinical trials in adults with advanced rare tumorsArjun Mittra, Naoko Takebe, Vaia Florou, et al.
Cells|May 13, 2023
Rethinking Oncologic Treatment Strategies with Interleukin-2Brian Ko, Naoko Takebe, Omozusi Andrews, et al.
Iscience|October 25, 2021
Schlafen 11 expression in human acute leukemia cells with gain-of-function mutations in the interferon-JAK signaling pathwayYasuhisa Murai, Ukhyun Jo, Junko Murai, et al.
Cancer Journal (Sudbury, Mass.)|July 24, 2019
Defining, Identifying, and Understanding "Exceptional Responders" in Oncology Using the Tools of Precision MedicineApostolia M Tsimberidou, Rabih Said, Louis M Staudt, et al.
The Journal of Biological Chemistry|May 10, 2012
Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) activity by small molecule GMX1778 regulates reactive oxygen species (ROS)-mediated cytotoxicity in a p53- and nicotinic acid phosphoribosyltransferase1 (NAPRT1)-dependent mannerDavid Cerna, Hongyun Li, Siobhan Flaherty, et al.
Growth Factors (Chur, Switzerland)|December 1, 2007
Human brain endothelial cells (HUBEC) promote SCID repopulating cell expansion through direct contactXiangfei Cheng, Thomas Macvittie, Barry Meisenberg, et al.
Cancer Gene Therapy|March 16, 2002
Methotrexate selection of long-term culture initiating cells following transduction of CD34(+) cells with a retrovirus containing a mutated human dihydrofolate reductase geneNaoko Takebe, Li-Cheng Xu, Karen L MacKenzie, et al.
Current Problems in Cancer|January 5, 2024
Blood-based multi-cancer detection: A state-of-the-art updateMaria Farooq, Elyse Leevan, Jibran Ahmed, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 12, 2016
Analysis of esophagogastric cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase 1 trialsHideaki Bando, Larry Rubinstein, Pamela Harris, et al.
Gynecologic Oncology|November 6, 2009
NIH and NCI support for development of novel therapeutics in gynecologic cancer: a user's guideLucas Minig, Edward L Trimble, Michael J Birrer, et al.
Pageof 14